The effect of lactulose on the faecal flora of patients with hepatic encephalopathy.
D001419:Bacteria / Q000187:drug effects*; D001431:Bacteriological Techniques; D001439:Bacteroides / Q000187:drug effects; D002452:Cell Count; D003013:Clostridium / Q000187:drug effects; D003201:Computers; D004035:Diet Therapy; D004044:Dietary Proteins / Q000627:therapeutic use; D004187:Disaccharides / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects; D005243:Feces / Q000382:microbiology*; D005260:Female; D006501:Hepatic Encephalopathy / Q000188:drug therapy / Q000382:microbiology* / Q000628:therapy; D006801:Humans; D007778:Lactobacillus / Q000187:drug effects; D007792:Lactulose / Q000494:pharmacology / Q000627:therapeutic use; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008297:Male; D013045:Species Specificity; D013291:Streptococcus / Q000187:drug effects
D004044:Dietary Proteins; D004187:Disaccharides; D007792:Lactulose; D008278:Magnesium Sulfate